These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23496828)

  • 1. Novel inhibitor binding site discovery on HIV-1 capsid N-terminal domain by NMR and X-ray crystallography.
    Goudreau N; Lemke CT; Faucher AM; Grand-Maître C; Goulet S; Lacoste JE; Rancourt J; Malenfant E; Mercier JF; Titolo S; Mason SW
    ACS Chem Biol; 2013 May; 8(5):1074-82. PubMed ID: 23496828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring binding of HIV-1 capsid assembly inhibitors using (19)F ligand-and (15)N protein-based NMR and X-ray crystallography: early hit validation of a benzodiazepine series.
    Goudreau N; Coulombe R; Faucher AM; Grand-Maître C; Lacoste JE; Lemke CT; Malenfant E; Bousquet Y; Fader L; Simoneau B; Mercier JF; Titolo S; Mason SW
    ChemMedChem; 2013 Mar; 8(3):405-14. PubMed ID: 23401268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of dual inhibitors targeting both HIV-1 capsid and human cyclophilin A to inhibit the assembly and uncoating of the viral capsid.
    Li J; Tan Z; Tang S; Hewlett I; Pang R; He M; He S; Tian B; Chen K; Yang M
    Bioorg Med Chem; 2009 Apr; 17(8):3177-88. PubMed ID: 19328002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships (SAR) research of thiourea derivatives as dual inhibitors targeting both HIV-1 capsid and human cyclophilin A.
    Chen K; Tan Z; He M; Li J; Tang S; Hewlett I; Yu F; Jin Y; Yang M
    Chem Biol Drug Des; 2010 Jul; 76(1):25-33. PubMed ID: 20456372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel inhibitor-binding site on the HIV-1 capsid N-terminal domain leads to improved crystallization via compound-mediated dimerization.
    Lemke CT; Titolo S; Goudreau N; Faucher AM; Mason SW; Bonneau P
    Acta Crystallogr D Biol Crystallogr; 2013 Jun; 69(Pt 6):1115-23. PubMed ID: 23695256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein.
    Lemke CT; Titolo S; von Schwedler U; Goudreau N; Mercier JF; Wardrop E; Faucher AM; Coulombe R; Banik SS; Fader L; Gagnon A; Kawai SH; Rancourt J; Tremblay M; Yoakim C; Simoneau B; Archambault J; Sundquist WI; Mason SW
    J Virol; 2012 Jun; 86(12):6643-55. PubMed ID: 22496222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of an NMR/Crystallography Fragment Screening Platform for the Assessment and Rapid Discovery of New HIV-CA Binding Fragments.
    Lang S; Fletcher DA; Petit AP; Luise N; Fyfe P; Zuccotto F; Porter D; Hope A; Bellany F; Kerr C; Mackenzie CJ; Wyatt PG; Gray DW
    ChemMedChem; 2024 Jul; 19(13):e202400025. PubMed ID: 38581280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophilin A stabilizes the HIV-1 capsid through a novel non-canonical binding site.
    Liu C; Perilla JR; Ning J; Lu M; Hou G; Ramalho R; Himes BA; Zhao G; Bedwell GJ; Byeon IJ; Ahn J; Gronenborn AM; Prevelige PE; Rousso I; Aiken C; Polenova T; Schulten K; Zhang P
    Nat Commun; 2016 Mar; 7():10714. PubMed ID: 26940118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation in the loop C-terminal to the cyclophilin A binding site of HIV-1 capsid protein disrupts proper virus assembly and infectivity.
    Abdurahman S; Höglund S; Höglund A; Vahlne A
    Retrovirology; 2007 Mar; 4():19. PubMed ID: 17371591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 2: structure-activity relationships (SAR) of the C3-phenyl moiety.
    Fader LD; Landry S; Goulet S; Morin S; Kawai SH; Bousquet Y; Dion I; Hucke O; Goudreau N; Lemke CT; Rancourt J; Bonneau P; Titolo S; Amad M; Garneau M; Duan J; Mason S; Simoneau B
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3401-5. PubMed ID: 23601710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications for viral capsid assembly from crystal structures of HIV-1 Gag(1-278) and CA(N)(133-278).
    Kelly BN; Howard BR; Wang H; Robinson H; Sundquist WI; Hill CP
    Biochemistry; 2006 Sep; 45(38):11257-66. PubMed ID: 16981686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of inhibitors of HIV-1 capsid assembly.
    Fader LD; Bethell R; Bonneau P; Bös M; Bousquet Y; Cordingley MG; Coulombe R; Deroy P; Faucher AM; Gagnon A; Goudreau N; Grand-Maître C; Guse I; Hucke O; Kawai SH; Lacoste JE; Landry S; Lemke CT; Malenfant E; Mason S; Morin S; O'Meara J; Simoneau B; Titolo S; Yoakim C
    Bioorg Med Chem Lett; 2011 Jan; 21(1):398-404. PubMed ID: 21087861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.
    Wang W; Zhou J; Halambage UD; Jurado KA; Jamin AV; Wang Y; Engelman AN; Aiken C
    J Virol; 2017 May; 91(9):. PubMed ID: 28202766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The capsid protein of human immunodeficiency virus: designing inhibitors of capsid assembly.
    Neira JL
    FEBS J; 2009 Nov; 276(21):6110-7. PubMed ID: 19825045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 1: addressing configurational instability through scaffold modification.
    Fader LD; Landry S; Morin S; Kawai SH; Bousquet Y; Hucke O; Goudreau N; Lemke CT; Bonneau P; Titolo S; Mason S; Simoneau B
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3396-400. PubMed ID: 23583513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalysis and binding of cyclophilin A with different HIV-1 capsid constructs.
    Bosco DA; Kern D
    Biochemistry; 2004 May; 43(20):6110-9. PubMed ID: 15147195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of HIV-1 capsid assembly: optimization of the antiviral potency by site selective modifications at N1, C2 and C16 of a 5-(5-furan-2-yl-pyrazol-1-yl)-1H-benzimidazole scaffold.
    Tremblay M; Bonneau P; Bousquet Y; DeRoy P; Duan J; Duplessis M; Gagnon A; Garneau M; Goudreau N; Guse I; Hucke O; Kawai SH; Lemke CT; Mason SW; Simoneau B; Surprenant S; Titolo S; Yoakim C
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7512-7. PubMed ID: 23122820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication.
    Thenin-Houssier S; de Vera IM; Pedro-Rosa L; Brady A; Richard A; Konnick B; Opp S; Buffone C; Fuhrmann J; Kota S; Billack B; Pietka-Ottlik M; Tellinghuisen T; Choe H; Spicer T; Scampavia L; Diaz-Griffero F; Kojetin DJ; Valente ST
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2195-208. PubMed ID: 26810656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationally designed interfacial peptides are efficient in vitro inhibitors of HIV-1 capsid assembly with antiviral activity.
    Bocanegra R; Nevot M; Doménech R; López I; Abián O; Rodríguez-Huete A; Cavasotto CN; Velázquez-Campoy A; Gómez J; Martínez MÁ; Neira JL; Mateu MG
    PLoS One; 2011; 6(9):e23877. PubMed ID: 21931621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The capsid protein of human immunodeficiency virus: intersubunit interactions during virus assembly.
    Mateu MG
    FEBS J; 2009 Nov; 276(21):6098-109. PubMed ID: 19825044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.